Quantcast

Latest MorphoSys AG Stories

2014-12-07 00:21:08

Results Show Durable Responses in High Risk Patient Population MARTINSRIED, Germany, MUNICH and MONROVIA, Calif., Dec.

2008-11-13 03:00:05

MARTINSRIED, Germany, Nov. 13, 2008 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) announced today the publication of preclinical data from its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF.

2008-09-02 03:00:00

MARTINSRIED, Germany, Sept.

2008-07-23 03:00:58

MARTINSRIED, Germany, July 23, 2008 (PRIME NEWSWIRE) -- MorphoSys AG (Frankfort:MOR) (Prime Standard Segment, TecDAX) announced today that Astellas Pharma Inc.

2008-07-17 03:00:38

MARTINSRIED, Germany, July 17, 2008 (PRIME NEWSWIRE) -- MorphoSys AG (FSE:MOR) (Prime Standard Segment, TecDAX) announced today that Phadia AB, a world leader in autoimmunity and allergy testing, has implemented a series of HuCAL-based recombinant antibodies in its marketed autoimmune tests Varelisa(tm) and EliA(tm).


Word of the Day
orbity
  • A bereavement by loss of parents or children; the state of being orbate; orbation.
The word 'orbity' ultimately comes from a Latin word meaning 'bereaved'.